142 related articles for article (PubMed ID: 26771189)
1. Upregulated Cellular Expression of IL-17 by CD4+ T-Cells in Osteoporotic Postmenopausal Women.
Zhao R; Wang X; Feng F
Ann Nutr Metab; 2016; 68(2):113-8. PubMed ID: 26771189
[TBL] [Abstract][Full Text] [Related]
2. IL-17A-mediated sRANK ligand elevation involved in postmenopausal osteoporosis.
Molnár I; Bohaty I; Somogyiné-Vári É
Osteoporos Int; 2014 Feb; 25(2):783-6. PubMed ID: 24337660
[TBL] [Abstract][Full Text] [Related]
3. Receptor activator of NF(Kappa)B ligand/osteoprotegerin (RANKL/OPG) system and osteopontin (OPN) serum levels in a population of apulian postmenopausal women.
D'Amore M; Fanelli M; D'Amore S; Fontana A; Minenna G
Panminerva Med; 2006 Dec; 48(4):215-21. PubMed ID: 17215793
[TBL] [Abstract][Full Text] [Related]
4. Circulating IL-17A Levels in Postmenopausal Women with Primary Hyperparathyroidism.
Dozio E; Passeri E; Vianello E; Palmieri S; Eller-Vainicher C; Corsi Romanelli M; Corbetta S
Mediators Inflamm; 2020; 2020():3417329. PubMed ID: 32256191
[TBL] [Abstract][Full Text] [Related]
5. Relationships among serum receptor of nuclear factor-kappaB ligand, osteoprotegerin, high-sensitivity C-reactive protein, and bone mineral density in postmenopausal women: osteoimmunity versus osteoinflammatory.
Nabipour I; Larijani B; Vahdat K; Assadi M; Jafari SM; Ahmadi E; Movahed A; Moradhaseli F; Sanjdideh Z; Obeidi N; Amiri Z
Menopause; 2009; 16(5):950-5. PubMed ID: 19387415
[TBL] [Abstract][Full Text] [Related]
6. The balance between soluble receptors regulating IL-6 trans-signaling is predictive for the RANKL/osteoprotegerin ratio in postmenopausal women with rheumatoid arthritis.
Oelzner P; Franke S; Lehmann G; Eidner T; Hein G; Wolf G
Rheumatol Int; 2012 Jan; 32(1):199-206. PubMed ID: 20821212
[TBL] [Abstract][Full Text] [Related]
7. The effect of risedronate treatment on serum cytokines in postmenopausal osteoporosis: a 6-month randomized and controlled study.
Dundar U; Kavuncu V; Ciftci IH; Evcik D; Solak O; Cakir T
J Bone Miner Metab; 2009; 27(4):464-70. PubMed ID: 19301089
[TBL] [Abstract][Full Text] [Related]
8. Increased augmentation index and central aortic blood pressure in osteoporotic postmenopausal women.
Mangiafico RA; Alagona C; Pennisi P; Parisi N; Mangiafico M; Purrello F; Fiore CE
Osteoporos Int; 2008 Jan; 19(1):49-56. PubMed ID: 17676381
[TBL] [Abstract][Full Text] [Related]
9. [The relationships between changes of serum osteoprotegerin, nuclear factor-kappa B ligand receptor activator, and age, menopause, bone biochemical markers and bone mineral densities in women aged 20 - 75].
Liu JM; Zhao HY; Ning G; Zhao YJ; Chen Y; Zhang LZ; Xu MY; Chen JL
Zhonghua Nei Ke Za Zhi; 2004 Jun; 43(6):447-50. PubMed ID: 15312444
[TBL] [Abstract][Full Text] [Related]
10. Relationships between insulin-like growth factor-I (IGF-I) and OPG, RANKL, bone mineral density in healthy Chinese women.
Zhao HY; Liu JM; Ning G; Zhao YJ; Chen Y; Sun LH; Zhang LZ; Xu MY; Chen JL
Osteoporos Int; 2008 Feb; 19(2):221-6. PubMed ID: 17703270
[TBL] [Abstract][Full Text] [Related]
11. Multiparameter analysis of serum levels of C-telopeptide crosslaps, bone-specific alkaline phosphatase, cathepsin K, osteoprotegerin and receptor activator of nuclear factor κB ligand in the diagnosis of osteoporosis.
Piatek S; Adolf D; Wex T; Halangk W; Klose S; Westphal S; Amthauer H; Winckler S
Maturitas; 2013 Apr; 74(4):363-8. PubMed ID: 23391500
[TBL] [Abstract][Full Text] [Related]
12. Effects of alendronate treatment on serum levels of osteoprotegerin and total receptor activator of nuclear factor kappaB in women with postmenopausal osteoporosis.
Reyes-García R; Muñoz-Torres M; García DF; Mezquita-Raya P; García Salcedo JA; de Dios Luna J
Menopause; 2010; 17(1):140-4. PubMed ID: 19574937
[TBL] [Abstract][Full Text] [Related]
13. Sera of patients with axial spondyloarthritis (axSpA) enhance osteoclastogenic potential of monocytes isolated from healthy individuals.
Korkosz M; Czepiel M; Guła Z; Stec M; Węglarczyk K; Rutkowska-Zapała M; Gruca A; Lenart M; Baran J; Gąsowski J; Błyszczuk P; Siedlar M
BMC Musculoskelet Disord; 2018 Dec; 19(1):434. PubMed ID: 30522483
[TBL] [Abstract][Full Text] [Related]
14. Gene-gene interactions in RANK/RANKL/OPG system influence bone mineral density in postmenopausal women.
Zupan J; Mencej-Bedrac S; Jurković-Mlakar S; Prezelj J; Marc J
J Steroid Biochem Mol Biol; 2010 Jan; 118(1-2):102-6. PubMed ID: 19896533
[TBL] [Abstract][Full Text] [Related]
15. Increased frequency of Th17 cells and IL-17 levels are associated with low bone mineral density in postmenopausal women.
Bhadricha H; Patel V; Singh AK; Savardekar L; Patil A; Surve S; Desai M
Sci Rep; 2021 Aug; 11(1):16155. PubMed ID: 34373550
[TBL] [Abstract][Full Text] [Related]
16. Immune system and bone metabolism: Does thymectomy influence postmenopausal bone loss in humans?
D'Amelio P; Grimaldi A; Bernabei P; Pescarmona GP; Isaia G
Bone; 2006 Sep; 39(3):658-65. PubMed ID: 16690366
[TBL] [Abstract][Full Text] [Related]
17. Assessment of OPG/RANK/RANKL gene expression levels in peripheral blood mononuclear cells (PBMC) after treatment with strontium ranelate and ibandronate in patients with postmenopausal osteoporosis.
Stuss M; Rieske P; Cegłowska A; Stêpień-Kłos W; Liberski PP; Brzeziańska E; Sewerynek E
J Clin Endocrinol Metab; 2013 May; 98(5):E1007-11. PubMed ID: 23543663
[TBL] [Abstract][Full Text] [Related]
18. Implications of measuring soluble receptor activators of nuclear factor-kappaB ligand and osteoprotegerin in bone metabolism of elderly women.
Chiba Y; Onouchi T; Ikeda T; Adachi J; Tamura Y; Horiuchi T
Gerontology; 2009; 55(3):275-80. PubMed ID: 19158438
[TBL] [Abstract][Full Text] [Related]
19. Serum osteopontin levels in relation to bone mineral density and bone turnover markers in postmenopausal women.
Wei QS; Huang L; Tan X; Chen ZQ; Chen SM; Deng WM
Scand J Clin Lab Invest; 2016; 76(1):33-9. PubMed ID: 26414945
[TBL] [Abstract][Full Text] [Related]
20. Bone loss in relation to serum levels of osteoprotegerin and nuclear factor-kappaB ligand: the Tromsø Study.
Jørgensen L; Vik A; Emaus N; Brox J; Hansen JB; Mathiesen E; Vestergaard P
Osteoporos Int; 2010 Jun; 21(6):931-8. PubMed ID: 19701599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
